Effect of voxel size and computation method on Tc-99m MAA SPECT/CT-based dose estimation for Y-90 microsphere therapy

IEEE Transactions on Medical Imaging

Volumn 28, Issue 11, 2009, Pages 1754-1758

  Pasciak, Alexander S ^a   Erwin, William D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Microsphere therapy; Monte Carlo dosimetry

Indexed keywords

ANTHROPOMORPHIC PHANTOMS; COMPUTATION METHODS; COMPUTATIONAL BURDEN; DOSE ESTIMATIONS; EVALUATION RESULTS; EXACT SOLUTION; HEPATOCELLULAR CARCINOMA; INTERNAL RADIATION; LIVER METASTASIS; LOCAL DEPOSITION; LOCAL ENERGY; MATRIX SIZE; MONTE CARLO; MONTE CARLO DOSIMETRY; MONTE CARLO SIMULATION; PATIENT SPECIFIC; RADIATION TRANSPORT; RECONSTRUCTION MATRIX; SIMULATION STUDIES; SOURCE DISTRIBUTION; SPECT/CT; UNIFORM DISTRIBUTION; VOXEL PHANTOMS; VOXEL SIZE;

DOSIMETERS; DOSIMETRY; MATRIX ALGEBRA; MICROSPHERES; REPAIR; SIMULATORS; TECHNETIUM; THREE DIMENSIONAL;

MONTE CARLO METHODS;

MACROSALB TC 99M; MICROSPHERE; YTTRIUM;

ALGORITHM; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; METHODOLOGY; MONTE CARLO METHOD; PATHOLOGY; RADIOGRAPHY; RADIOMETRY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THEORETICAL MODEL;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER NEOPLASMS; MICROSPHERES; MODELS, THEORETICAL; MONTE CARLO METHOD; PHANTOMS, IMAGING; RADIOMETRY; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; YTTRIUM ISOTOPES;

EID: 70350755614     PISSN: 02780062     EISSN: None     Source Type: Journal    
DOI: 10.1109/TMI.2009.2022753     Document Type: Article

References (23)

1. I. M. Ariel, "Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres)," Ann. Surg., vol.162, pp. 267-278, 1965.
2. L. Lim et al., "Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies," Int. Med. J., vol.35, pp. 222-227, 2005.
3. R. Murthy et al, "Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: Preliminary results," J. Vasc. Inter. Radiol., vol.16, pp. 937-945, 2005.
4. B. I. Carr, "Hepatic arterial 90Yttrium glass microspheres (TheraS-phere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients," Liver Trans., vol.10, pp. S107-S110, 2004.
5. D. Minarik, K. S. Gleisner, and M. Ljungberg, "Evaluation of quantitative 90Y SPECT based on experimental phantom studies," Phys. Med. Biol., vol.53, pp. 5689-5703, 2008.
6. M. J. Herba, F. F. Illescase, M. P. Thirlwell, G. J. Boos, L. Rosenthall, M. Atri, and P. M. Bret, "Hepatic malignancies: Improved treatment with intraarterial Y-90," Radiology, vol.169, pp. 311-314, 1988.
7. R. Mantravadi, D. Spigos, W. Tan, and E. L. Felix, "Intraarterial yttrium 90 in the treatment of hepatic malignancy," Radiology, vol.142, pp. 783-786, 1982.
8. F. Shepherd, L. Rostein, S. Houle, T. Yip, K. Paul, and K. W. Sni-derman, "A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma," Cancer, vol.70, pp. 2250-2254, 1992.
9. S. A. Gulec, M. Geraldine, and M. Stabin, "Dosimetric techniques in 00 Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations," J. Nucl. Med., vol.47, no.7, pp. 1209-1211, 2006.
10. W. Leung, W. Lau, S. K. Ho, M. Chan, N. W. Leung, J. Lin, C. Metreweli, P. J. Johnson, and A. K. Li, "Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin," J. Nucl. Med., vol.35, no.1, pp. 70-73, Jan. 1994.
11. S. Gulec, G. Mesoloras, W. Dezarn, P. McNeillie, and A. Kennedy, "Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio," J. Trans. Med., vol.5, no.15, 2007.
12. S. Ho, W. Lau, T. W. T. Leung, M. Chan, K. Chan, W. Lee, P. J. Johnson, and A. K. Li, "Tumor-to-normal uptake ratio of 00 Y microspheres in hepatic cancer assessed with "TcM macroaggregated albumin," Brit. J. Radiol., vol. 70, pp. 823-828, Aug. 1997.
13. S. Ho, W. Lau, T. Leung, M. Chan, Y. Ngar, P. Johnson, and A. K. Li, "Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumors," Eur. J. Nucl. Med., vol.23, pp. 947-952, 1996.
14. S. Ho, W. Lau, T. Leung, M. Chan, Y. Ngar, P. Johnson, and A. Li, "Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer," Eur. J. Nucl. Med., vol.24, pp. 293-298, 1997.
15. E. Furhan, C. Chui, K. Kolbert, S. Larson, andG. Sgouros, "Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy," Med. Phys., vol.24, pp. 1163-1172, 1997.
16. H. Yorivaz, A. Santos, M. Stabin, and R. Cabezas, "Absorbed fractions in a voxel-based phantom calculated with the MCNP-4B code," Med. Phys., vol.27, pp. 1555-1562.
17. M. Ljungberg, K. Green, X. Liu, E. Frey, Y. Dewaraja, and S. Strand, "A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: Evaluation for 131I using Monte Carlo simulation," J. Nucl. Med., vol.43, 2002.
18. M. Descalle, C. Siantar, L. Dauffy, D. Nigg, C. Wemple, A. Yuan, and G. Denardo, "Application of MINERVA Monte Carlo simulations to targeted radionuclide therapy," Cancer Bio-Therapy Radiopharm., vol.18, pp. 71-79, 2003.
19. S. Wilderman and Y. Dewaraja, "Method for fast CT/SPECT-Based 3D Monte Carlo absorbed dose computations in internal emitter therapy," IEEE Trans. Nucl. Sci., vol.54, no.1, pp. 146-151, Feb. 2007.
20. W. E. Bolch, L. G. Bouchet, J. S. Robertson, B. Wessels, J. Siegel, R. Howell, A. Erdi, B. Aydogan, S. Costes, and E. Watson, "MIRD Pamphlet No. 17: The dosimetry of nonuniform activity distributions-radionuclide S values at the voxel level," J. Nucl. Med., no.40, pp. 11S-36S, 1999.
21. B. Vanderstraeten, P. Chin, M. Fix, A. Leal, G. Mora, N. Reynaert, J. Seco, M. Soukup, E. Spezi, W. Neve, and H. Thierens, "Conversion of CT numbers into tissue parameters for Monte Carlo dose calculations: A multi-centre study," Phys. Med. Biol., vol.52, pp. 539-562, 2007.
22. G. McKinney, J. Durkee, J. Kendricks, M. James, D. Pelowitz, L. Waters, and F. Gallmeir, MCNPX Overview Los Alamos Nat. Lab., Los Alamos, NM, LA-UR-06-6206, 2006.
23. S. Kneifel, P. Bernhardt, H. Uusijarvi, S. Good, L. Plasswilm, C. Buitrago-Tellez, J. Muller-Brans, H. Macke, and A. Merlo, "Individual voxelwise dosimetry of targeted 90Y-labelled substance P radiotherapy for malignant gliomas," Nucl. Med. Mol. Imag., vol.34, pp. 1388-1395, 2007.